Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess the effect of a novel clinical decision support application on the rate of perioperative medication errors and preventable adverse medication events. The investigators hypothesize that the perioperative clinical decision support application will reduce the incidence of perioperative medication errors and adverse medication events compared to the standard of care.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Perioperative Clinical Decision Support Application | Experimental | Participants will be observed performing clinical tasks and documenting medication administrations with use of the clinical decision support application in the perioperative setting. |
|
| No Perioperative Clinical Decision Support Application | No Intervention | Participants will be observed performing clinical tasks and documenting medication administrations without use of the clinical decision support application in the perioperative setting. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Electronic Clinical Decision Support Application | Other | Robust, real-time medication-related clinical decision support application for use in the operating room. The application is fully integrated with existing clinical systems. It provides visual alerts for medication errors and adverse medication events at the point-of-care. |
| Measure | Description | Time Frame |
|---|---|---|
| Combined incidence of medication errors and adverse medication events in the perioperative setting | Number of medication errors and adverse medication events / number of medications administered | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of medication errors the perioperative setting | Number of errors / number of medications administered | 6 months |
| Incidence of adverse medication events in the perioperative setting | Number of adverse medication events / number of medications administered |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Karen C Nanji, M.D., M.P.H. | Contact | (617) 724-8544 | KNANJI@mgh.harvard.edu |
| Name | Affiliation | Role |
|---|---|---|
| Karen C Nanji, M.D., M.P.H. | Massachusetts General Hospital | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26501385 | Background | Nanji KC, Patel A, Shaikh S, Seger DL, Bates DW. Evaluation of Perioperative Medication Errors and Adverse Drug Events. Anesthesiology. 2016 Jan;124(1):25-34. doi: 10.1097/ALN.0000000000000904. |
Not provided
Not provided
Not provided
Randomized, non-blinded, parallel-arm clinical trial to assess the incidence of medication errors and adverse medication events with and without the use of an electronic clinical decision support application.
Not provided
Not provided
Not provided
Not provided
|
| 6 months |
| Preventability of medication errors and adverse medication events | Four-point Likert scale for preventability: definitely preventable, probably preventable, probably not preventable, and definitely not preventability | 6 months |
| Severity of harm (or potential harm) associated with both medication errors and adverse medication events in the perioperative setting | Four-point Likert scale for severity: Fatal Life-threatening: The event has the potential to cause symptoms that if not treated would put the patient at risk of death. Serious: The event has the potential to cause symptoms that are associated with a serious level of harm that is not high enough to be life-threatening. Significant: The event has the potential to cause symptoms that while harmful to the patient pose little or no threat to the patient's function. | 6 months |